Cancer doesn’t discriminate, but access to great cancer care hasn’t always been the same for everyone. At Providence, we are deeply committed to making sure every patient we treat has access to the best cancer care. We value, respect and support the racial, ethnic, religious, gender, sexual and spiritual identities of each member of our diverse communities, and we never turn a patient away. Instead, we work harder to make sure every patient is treated equally and with dignity – whoever you are, and wherever you're at.

When you become a patient at Providence, you become part of a collaborative cancer-care network that often exceeds national measures for patient outcomes. This network includes award-winning physicians, scientists, researchers and caregivers across 51 hospitals in seven states. The power of this network, combined with the expertise of your local team, means you’re getting the best, most compassionate care. And if you need to meet with a specialist outside your area, we’ve got telehealth technology to help. Our network is one of the reasons 50,000 newly diagnosed cancer patients choose Providence each year.

Providence cancer research provides options, and hope, for patients seeking advanced therapies. We’re proud of our history of groundbreaking firsts and pioneering clinical trials: Providence led the international trial of the first immunotherapy to be approved for patients with melanoma. We conducted the first successful gene-engineered T-cell therapy for metastatic pancreatic cancer. And we have over 90 years of radiation research. As a Providence patient, you have the opportunity to participate in – or benefit from – one of over 1,300 new clinical trials that begin each year.